Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Matthias Schroff
|
| gptkbp:focus |
nucleic acid therapeutics
|
| gptkbp:foundedYear |
2011
|
| gptkbp:founder |
gptkb:Chad_Mirkin
|
| gptkbp:hasCompany |
true
|
| gptkbp:headquartersLocation |
gptkb:Chicago,_Illinois,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Exicure, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:products |
oncology
genetic disorders neurological diseases |
| gptkbp:stockSymbol |
XCUR
|
| gptkbp:technology |
spherical nucleic acid (SNA) platform
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.exicuretx.com/
|
| gptkbp:bfsParent |
gptkb:Chad_Mirkin
|
| gptkbp:bfsLayer |
7
|